| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| nxn-188 | 5-ht 1b receptor | NA | Successful target | TTD , DGIDB | Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 2 | unknown |
| nxn-188 | 5-hydroxytryptamine receptor 1b | small molecule | NA | drugbank , DGIDB | Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
| nxn-188 | 5-ht 1d receptor | NA | Successful target | TTD , DGIDB | Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 2 | unknown |
| nxn-188 | 5-hydroxytryptamine receptor 1d | small molecule | NA | drugbank , DGIDB | Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
| nxn-188 | nitric-oxide synthase brain | NA | Clinical trial target | TTD , DGIDB | Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 2 | unknown |
| nxn-188 | nitric oxide synthase, brain | small molecule | NA | drugbank , DGIDB | Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
| click here to return to the previous page | ||||||||